Saline Stulln
Natural health product licensed in Canada
- Other names
- Sodium Chloride Ophthalmic Solution
- Licence holder
- Pharma Stulln Inc.
- NPN or DIN-HM
- 80127042
- Status
- Active licence
- Licence date
- 26 September 2023
- Revision date
- Not provided
- Form
- Solution
- Route of administration
- Ophthalmique
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau pour injections
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescents et adultes | minimum: 12 years | minimum: 1 Goutte(s) ; maximum: 2 Goutte(s) | minimum: 3 hours ; maximum: 4 hours |
| Enfants | minimum: 2 years ; maximum: 11 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
For the temporary relief of corneal edema
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80127042
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.